Last reviewed · How we verify
resorcinol
resorcinol is a drug. It is currently in unknown development for Acne vulgaris, Acneiform eruption, Itching of skin.
Resorcinol is a small molecule organic compound with the formula C6H4(OH)2, classified as a phenolic compound and one of three isomeric benzenediols. It is used in a 0.2% concentration in a cream as an intervention in clinical trials for conditions such as wrinkles, facial hyperpigmentation, melasma, and hydradenitis.
At a glance
| Generic name | resorcinol |
|---|---|
| Target | Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2 |
| Therapeutic area | Pain |
| Phase | unknown |
Approved indications
- Acne vulgaris
- Acneiform eruption
- Itching of skin
- Minor Skin Wound Pain
- Skin irritation
Common side effects
Key clinical trials
- The Efficacy of Melanostop Peel in Combination With Specifically Selected Home Care Regimen for Improvement of Melasma (NA)
- OBSERVATIONAL CASE-ONLY PROSPECTIVE STUDY OF EFFECTIVENESS AND SAFETY OF 15% TOPICAL RESORCINOL FOR ADULTS WITH HURLEY I-II HIDRADENITIS SUPPURATIVA. (N/A)
- Treatment of Lateral Canthal Rhytides With Medium Depth Chemical Peel With or Without Pretreatment With Botulinum Toxin A: A Split-face, Rater-blinded Randomized Control Trial (Phase 3)
- PDT Versus the Combination of Jessner's Solution and 35% TCA for Treatment of Actinic Keratoses on Upper Extremities: A Randomized Controlled Split-arm Trial (Phase 2)
- Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation, A Randomized Double-blind and Vehicle-Controlled Study (NA)
- Evaluation of the Efficacy of the Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- resorcinol CI brief — competitive landscape report
- resorcinol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about resorcinol
What is resorcinol?
What is resorcinol used for?
What development phase is resorcinol in?
What does resorcinol target?
Related
- Target: All drugs targeting Carbonic anhydrase 12, Carbonic anhydrase 14, Carbonic anhydrase 2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
- Indication: Drugs for Acne vulgaris
- Indication: Drugs for Acneiform eruption
- Indication: Drugs for Itching of skin
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing